Skip to Main Content

AANS/CNS Section on Tumors II

Wednesday, May 2 | 2:00 pm - 5:00 pm | 395/396; Ernest N. Morial

Moderator(s): Steven N. Kalkanis, MD, FAANS; Rohan Ramakrishna, MD, FAANS

Add to Calendar Wednesday, May 2 Wednesday, May 2 America/Chicago AANS/CNS Section on Tumors II 395/396; Ernest N. Morial

2:00 pm - 2:05 pm

Introduction to the Session: The Promise of Viral Oncolytic Therapy

5/2/2018 2:00:00 PM 5/2/2018 2:05:00 PM Introduction to the Session: The Promise of Viral Oncolytic Therapy 395/396; Ernest N. Morial

2:06 pm - 2:22 pm

History and Potential Future Applications of Oncolytic Virus Therapy

5/2/2018 2:06:00 PM 5/2/2018 2:22:00 PM History and Potential Future Applications of Oncolytic Virus Therapy 395/396; Ernest N. Morial

2:23 pm - 2:39 pm

Oncolytic Adenoviruses: Clinical Trials and the Delivery Problem

5/2/2018 2:23:00 PM 5/2/2018 2:39:00 PM Oncolytic Adenoviruses: Clinical Trials and the Delivery Problem 395/396; Ernest N. Morial

2:40 pm - 2:56 pm

Oncolytic Adenoviruses and Immunotherapy for Gliomas

5/2/2018 2:40:00 PM 5/2/2018 2:56:00 PM Oncolytic Adenoviruses and Immunotherapy for Gliomas 395/396; Ernest N. Morial

2:57 pm - 3:13 pm

GBM Clinical Trials with Viral Based Gene Therapies: Resurrection of an Old Paradigm

5/2/2018 2:57:00 PM 5/2/2018 3:13:00 PM GBM Clinical Trials with Viral Based Gene Therapies: Resurrection of an Old Paradigm 395/396; Ernest N. Morial

3:14 pm - 3:30 pm

Oncolytic HSV and Immunotherapy for Adults and Children with Glioma

5/2/2018 3:14:00 PM 5/2/2018 3:30:00 PM Oncolytic HSV and Immunotherapy for Adults and Children with Glioma 395/396; Ernest N. Morial

3:31 pm - 3:40 pm

759. Microglia-glioblastoma interactions influence clinical survival

5/2/2018 3:31:00 PM 5/2/2018 3:40:00 PM 759. Microglia-glioblastoma interactions influence clinical survival 395/396; Ernest N. Morial

3:41 pm - 3:50 pm

760. Outcomes of Adoptive Cell Transfer with Tumor-Infiltrating Lymphocytes for Metastatic Melanoma Patients with and without Brain Metastases

5/2/2018 3:41:00 PM 5/2/2018 3:50:00 PM 760. Outcomes of Adoptive Cell Transfer with Tumor-Infiltrating Lymphocytes for Metastatic Melanoma Patients with and without Brain Metastases 395/396; Ernest N. Morial

3:51 pm - 4:00 pm

761. Tumor-Induced Immunosuppression Promotes Brain Metastasis in Patients with Non-Small Cell Lung Cancer

5/2/2018 3:51:00 PM 5/2/2018 4:00:00 PM 761. Tumor-Induced Immunosuppression Promotes Brain Metastasis in Patients with Non-Small Cell Lung Cancer 395/396; Ernest N. Morial

4:01 pm - 4:10 pm

762. Activation of Canonical EGFR Pathway in Cushing’s Disease

5/2/2018 4:01:00 PM 5/2/2018 4:10:00 PM 762. Activation of Canonical EGFR Pathway in Cushing’s Disease 395/396; Ernest N. Morial

4:11 pm - 4:20 pm

763. Antitumor Efficacy Of Anti-PDL-1 In ACTH-Secreting Pituitary Adenomas: An Immunotherapeutic Approach For Cushing’s Disease

5/2/2018 4:11:00 PM 5/2/2018 4:20:00 PM 763. Antitumor Efficacy Of Anti-PDL-1 In ACTH-Secreting Pituitary Adenomas: An Immunotherapeutic Approach For Cushing’s Disease 395/396; Ernest N. Morial

4:21 pm - 4:30 pm

764. Comparison of Intraoperative Imaging with Receptor-specific versus Passive Delivery of Near-Infrared Dyes in Human Pituitary Adenoma Surgery

5/2/2018 4:21:00 PM 5/2/2018 4:30:00 PM 764. Comparison of Intraoperative Imaging with Receptor-specific versus Passive Delivery of Near-Infrared Dyes in Human Pituitary Adenoma Surgery 395/396; Ernest N. Morial

4:31 pm - 4:40 pm

765. Treatment response assessment maps (TRAMs): increased/decreased sensitivity to tumor/treatment-effects as a function of time post contrast injection

5/2/2018 4:31:00 PM 5/2/2018 4:40:00 PM 765. Treatment response assessment maps (TRAMs): increased/decreased sensitivity to tumor/treatment-effects as a function of time post contrast injection 395/396; Ernest N. Morial

4:41 pm - 4:50 pm

769. The Development of a Technical Skills Test for Objective Assessment in Neuroendoscopic Education

5/2/2018 4:41:00 PM 5/2/2018 4:50:00 PM 769. The Development of a Technical Skills Test for Objective Assessment in Neuroendoscopic Education 395/396; Ernest N. Morial

4:51 pm - 5:00 pm

768. Enhanced 5-ALA induced Fluorescence in Hormone Secreting Pituitary Adenomas

5/2/2018 4:51:00 PM 5/2/2018 5:00:00 PM 768. Enhanced 5-ALA induced Fluorescence in Hormone Secreting Pituitary Adenomas 395/396; Ernest N. Morial